Sleep Apnea Devices Market Size, Share & Trends by products (Therapeutic (PAP (CPAP, APAP, BPAP)), Facial Interfaces, Oral Appliances, Accessories), Diagnostic Devices (PSG, Home Sleep Testing, Oximeters), Age Group, Gender type, End User & Region - Global Forecasts to 2029
Report Code: MD 1181 Jul, 2024, by marketsandmarkets.com
Sleep Apnea Devices Market Size, Share & Trends
The size of global sleep apnea devices market in terms of revenue was estimated to be worth $6.5 billion in 2024 and is poised to reach $9.3 billion by 2029, growing at a CAGR of 7.3% from 2024 to 2029. The market also observes lucrative growth opportunities with growing adoption of telemedicine, mHealth and artificial intelligence for treatment and diagnosis of sleep apnea along with expansion of leading players into emerging countries such as India, Australia, UAE and Saudi Arabia. There has been an increasing trend of health agencies expanding the reimbursement coverage of remote patient monitoring and other connected health services. On the other hand, products like compact PAP machines, wearable sleep monitors are gaining popularity in the sleep apnea devices market.
Sleep Apnea Devices Market Trends
To know about the assumptions considered for the study, Request for Free Sample Report
Sleep apnea devices Market Dynamics
DRIVER: Increased investments and funding for advancement of sleep apnea products
Increased investments and funding expenditure by leading manufacturers for innovations in sleep apnea products are driving significant innovations in the market, such as the development of more comfortable, efficient, and user-friendly CPAP devices and diagnostics. These rise of investments leads to improving research and development, resulting in innovative technologies which further improve patient compliance and therapeutic outcomes. Additionally, these funding supports led to expanded market reach and improved accessibility to advanced sleep apnea solutions across the globe.
RESTRAINT: Insufficient awareness of sleep apnea
Insufficient awareness of sleep apnea and its further health consequences to restraint the growth of sleep apnea devices market. It has been reported that several individuals remain undiagnosed and are unaware of sleep apnea as they fail to recognize the symptoms or understand the risks associated with the condition. This underdiagnosis of sleep apnea leads to less number of people seeking necessary medical intervention and utilizing the available therapeutic options, which is further limiting the market expansion.
OPPORTUNITY: Rising adoption of the cost-effective home sleep apnea tests
An increasing number of people are opting for the home treatments due to the huge out-of-pocket expenditure healthcare costs in hospital settings. The home healthcare market includes many devices, including sleep apnea diagnostic and therapeutic devices. These devices and services provide patients with cost-effective healthcare. Several next-generation sleep-sensing technologies are emerging as effective tools for home sleep apnea tests (HSATs), offering comfort and ease of access. Improving home sleep apnea testing and management is expected to generate more opportunities for growth in the sleep apnea devices market.
CHALLENGE: Lesser compliance rate associated with CPAP devices
CPAP comes with several disadvantages and a negative patient compliance record. Poor adherence to CPAP limits its clinical effectiveness, leading to a need for additional therapeutic options. CPAP devices are noisy, large, and have ill-fitting masks. In addition, sleep apnea patients at times feel discomfort due to the flow of the air during exhalation. To overcome these issues, device manufacturers are working towards developing CPAP devices that are smaller and quieter. Furthermore, in 2024, University of Cincinnati researchers announced development of a new CPAP devices called the VortexPAP providing better fit, airflow and sound.
Sleep apnea devices Ecosystem/Market Map
PAP devices segment accounted for the largest share among therapeutic devices of the sleep apnea devices industry in 2023, by product.
The sleep apnea devices market is categorized into positive airway pressure (PAP) devices, facial interfaces (masks), accessories, oral appliances, and other therapeutic devices, based on the product. In 2023, the PAP devices segment emerged as the leading sector in the sleep apnea devices market. The large share of this segment can majorly be attributed to the continuous devices innovation to make it smaller quieter and more comfortable.
;The largest share in the sleep apnea devices industry in 2023 was held by the home care settings/individuals, by end user.
Categorized by its various end users, the sleep apnea devices market includes sleep laboratories, clinics, and hospitals and home care settings/individuals. As of 2023, the largest portion of the market was dominated by the home care settings/individuals segment. Sleep laboratories, clinics and hospitals segment to observe growth due to advancing infrastructure, and innovative diagnostic and therapy devices.
Asia Pacific observed the highest growth rate of the sleep apnea devices industry in 2023.
Categorized into six primary regions, namely North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries, the sleep apnea devices market witnessed North America taking the forefront in 2023However, Asia Pacific region is expected to observe highest growth rate in the market as large patient pool influenced with comorbidities such as obesity and aging coupled with large population of undiagnosed sleep apnea patients indicate a massive potential for the Asia Pacific market. Countries in the region are also observing increase in sleep clinics over the last few years. On the other hand, leading players in sleep apnea market are adopting inorganic growth strategies to expand their presence in countries like India and Australia.
To know about the assumptions considered for the study, download the pdf brochure
The major players in this market are ResMed (US), Koninklijke Philips N.V. (Netherlands), and Fisher & Paykel Healthcare Limited (New Zealand). These players lead the market because of their extensive product portfolios and wide geographic presence.
Scope of the Sleep Apnea Devices Industry:
|
Report Metric |
Details |
|
Market Revenue in 2024 |
$6.5 billion |
|
Projected Revenue by 2029 |
$9.3 billion |
|
Revenue Rate |
Poised to Grow at a CAGR of 7.3% |
|
Market Driver |
Increased investments and funding for advancement of sleep apnea products |
|
Market Opportunity |
Rising adoption of the cost-effective home sleep apnea tests |
This report categorizes the sleep apnea devices market to forecast revenue and analyze trends in each of the following submarkets:
By Product
-
Therapeutic Devices
-
PAP Devices
- CPAP Devices
- APAP Devices
- BPAP Devices
-
Facial Interfaces
-
Masks
- Full-face Masks
- Nasal Pillow Masks
- Nasal Masks
- Cushions
-
Masks
-
Accessories
- Humidifiers Accessories
- Power Accessories
- Transportation Accessories
- Communication Accessories
- Chin Restraints
- Other Accessories
-
Oral Appliances
- Mandibular Advancement Devices
- Tongue-retaining Devices
- Daytime-Nighttime Appliances
- Other Therapeutic Devices
-
PAP Devices
-
Diagnostic Devices
-
PSG Devices
- Abulatory PSG Devices
- Clinical PSG Devices
- Home Sleep Testing Devices
-
Oximeters
- Fingertip Oximeters
- Handheld Oximeters
- Wrist-worn Oximeters
- Tabletop Oximeters
- Actigraphy Systsems
- Sleep Screening Devices
-
PSG Devices
By End User
- Sleep Laboratories, Clinics, and Hospitals
- Home Care Settings/ Individuals
By Age Group
- Below 40 Years
- 40-60 Years
- Above 60 Years
By Gender
- Male Patients
- Female Patients
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
-
Asia Pacific
- Japan
- China
- Australia
- Rest of Asia Pacific
-
Latin America
- Brazil
- Mexico
- Rest of Latin America
-
Middle East & Africa
-
GCC Countries
- Kingdom of Saudi Arabia
- UAE
- Other GCC Countries
-
GCC Countries
Recent Developments of Sleep Apnea Devices Industry:
- In June 2024, ResMed (US) launched Airfit f40, an ultra-compact, full-face mask offering the comfort of smaller masks to improve sleep apnea therapy compliance.
- In April 2024, Fisher & Paykel Healthcare Limited (New Zealand) launched Autofit nasal and pillow masks to simplify the setup process in the US.
- In May 2023, Dynaflex (US) acquired Whole You, Inc. (US), a US sleep and respiratory care therapeutic segment leader. Whole You, Inc. has led the sleep apnea oral appliances market for the past decade.
- In November 2022, ResMed (US) opened its new 25,000-square-meter advanced manufacturing center in Tuas, Singapore, to serve as ResMed’s key manufacturing hub in the Asia Pacific.
- In October 2021, ResMed (US) acquired ectosense, a cloud-connected home sleep test (hst) leader, to expand its sleep apnea product offerings.
Frequently Asked Questions (FAQ):
What is the projected market value of the global sleep apnea devices market?
The global market of sleep apnea devices is projected to reach USD 9.3 Billion by 2029
What is the estimated growth rate (CAGR) of the global sleep apnea devices market for the next five years?
The global Sleep apnea devices market is projected to grow at a Compound Annual Growth Rate (CAGR) of 7.3% from 2024 to 2029. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 35)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 SEGMENTS COVERED
1.3.2 REGIONS COVERED
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 40)
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 List of key secondary sources
2.1.1.2 Key data from secondary sources
2.1.1.3 Objectives of secondary research
2.1.2 PRIMARY DATA
2.1.2.1 List of key primaries
2.1.2.2 Objectives of primary research
2.1.2.3 Key industry insights
2.1.2.4 Key data from primary sources
2.1.2.5 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Company revenue estimation approach
2.2.1.2 Company presentations and primary interviews
2.2.1.3 Patient-based approach (sleep apnea oral appliances)
2.2.1.4 Patient-based approach (PAP devices)
2.2.1.5 Growth forecast
2.2.1.6 CAGR projections
2.2.2 TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
2.4 MARKET SHARE ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ASSESSMENT
3 EXECUTIVE SUMMARY (Page No. - 54)
4 PREMIUM INSIGHTS (Page No. - 58)
4.1 SLEEP APNEA DEVICES MARKET OVERVIEW
4.2 SLEEP APNEA DEVICES MARKET, BY PRODUCT (2024–2029)
4.3 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY PRODUCT AND COUNTRY (2023)
4.4 GEOGRAPHIC GROWTH OPPORTUNITIES (2024–2029)
5 MARKET OVERVIEW (Page No. - 61)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Large pool of undiagnosed sleep apnea patients
5.2.1.2 Favorable reimbursement and financial aid for sleep apnea devices and therapies
5.2.1.3 Growing awareness about effects of untreated sleep apnea among patients
5.2.1.4 Increasing usage of oral appliances among patients with mild-to-moderate sleep apnea
5.2.1.5 Increased investments and funding to develop advanced sleep apnea products
5.2.2 RESTRAINTS
5.2.2.1 High cost of CPAP machines and minimal insurance access in emerging economies
5.2.2.2 Complex referral pathways, long waiting periods, and delayed diagnosis
5.2.2.3 Use of alternative therapies and medications for sleep apnea
5.2.3 OPPORTUNITIES
5.2.3.1 Rising demand for cost-effective home sleep apnea tests
5.2.3.2 Increasing focus on telemedicine, mHealth, and artificial intelligence
5.2.3.3 Growing focus of key sleep apnea device manufacturers toward emerging markets
5.2.4 CHALLENGES
5.2.4.1 Poor patient compliance with CPAP therapy
5.3 PRICING ANALYSIS
5.3.1 AVERAGE SELLING PRICE OF SLEEP APNEA PRODUCTS, BY REGION
5.3.2 AVERAGE SELLING PRICE RANGE, BY PRODUCT TYPE
5.4 VALUE CHAIN ANALYSIS
5.5 SUPPLY CHAIN ANALYSIS
5.6 PORTER’S FIVE FORCES ANALYSIS
5.6.1 THREAT OF NEW ENTRANTS
5.6.2 THREAT OF SUBSTITUTES
5.6.3 BARGAINING POWER OF SUPPLIERS
5.6.4 BARGAINING POWER OF BUYERS
5.6.5 INTENSITY OF COMPETITIVE RIVALRY
5.7 KEY STAKEHOLDERS & BUYING CRITERIA
5.7.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.7.2 KEY BUYING CRITERIA
5.8 ECOSYSTEM ANALYSIS
5.8.1 ROLE IN ECOSYSTEM
5.9 REGULATORY ANALYSIS
5.9.1 REGULATORY LANDSCAPE
5.9.1.1 North America
5.9.1.1.1 US
5.9.1.1.1.1 Reimbursement scenario in US
5.9.1.1.2 Canada
5.9.1.2 Europe
5.9.1.3 Asia Pacific
5.9.1.3.1 Japan
5.9.1.3.2 China
5.9.1.3.3 India
5.9.1.3.4 Australia
5.9.2 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.9.2.1 List of key regulatory bodies, government agencies, and other organizations
5.9.2.1.1 North America
5.9.2.1.2 Europe
5.9.2.1.3 Asia Pacific
5.9.2.1.4 Latin America
5.9.2.1.5 Middle East & Africa
5.9.2.2 List of other regulatory bodies, government agencies, and other organizations
5.10 PATENT ANALYSIS
5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.11.1 REVENUE SHIFT AND POCKETS FOR SLEEP APNEA ORAL APPLIANCE MANUFACTURERS
5.12 KEY CONFERENCES & EVENTS, 2024−2025
5.13 TECHNOLOGY ANALYSIS
5.13.1 KEY TECHNOLOGIES
5.13.1.1 PAP devices
5.13.2 ADJACENT TECHNOLOGIES
5.13.2.1 Oral appliances
5.14 TRADE ANALYSIS
5.14.1 IMPORT DATA FOR HS CODE 901920
5.14.2 EXPORT DATA FOR HS CODE 901920
5.15 INVESTMENT & FUNDING SCENARIO
5.16 IMPACT OF GENERATIVE AI ON SLEEP APNEA DEVICES MARKET
6 EPIDEMIOLOGICAL ASSESSMENT OF SLEEP APNEA (Page No. - 96)
6.1 INTRODUCTION
6.2 EPIDEMIOLOGICAL ASSESSMENT
6.3 PRESCRIPTION PATTERN ASSESSMENT
6.4 ADHERENCE ASSESSMENT
7 ALTERNATE THERAPIES FOR SLEEP APNEA (Page No. - 100)
7.1 INTRODUCTION
7.2 EXPIRATORY PAP
7.3 HYPOGLOSSAL NERVE STIMULATION
7.4 ORAL PRESSURE THERAPY
7.5 POSITIONAL THERAPY
8 SLEEP APNEA DEVICES MARKET, BY PRODUCT (Page No. - 103)
8.1 INTRODUCTION
8.2 THERAPEUTIC DEVICES
8.2.1 PAP DEVICES
8.2.2 CPAP DEVICES
8.2.2.1 Technological advancements and better reimbursement facilities to boost segment growth
8.2.3 APAP DEVICES
8.2.3.1 Increasing patient non-compliance with CPAP devices to augment segment growth
8.2.4 BPAP DEVICES
8.2.4.1 Increased product recalls and more complex operations to lower adoption
8.2.5 FACIAL INTERFACES
8.2.5.1 Masks
8.2.5.1.1 Full-face masks
8.2.5.1.1.1 Full-face masks to be most effective for mouth breathers or patients struggling with breathing through nose
8.2.5.1.2 Nasal pillow masks
8.2.5.1.2.1 Greater patient compliance and high preference for masks without headgear or straps to support segment
8.2.5.1.3 Nasal masks
8.2.5.1.3.1 Ease of use and less claustrophobic nature to aid adoption
8.2.5.2 Cushions
8.2.5.2.1 Favorable insurance coverage to propel segment growth
8.2.6 ACCESSORIES
8.2.6.1 Humidifier accessories
8.2.6.1.1 Humidifiers to open airways, decrease congestion, and encourage clearer breathing
8.2.6.2 Power accessories
8.2.6.2.1 Power accessories to manage uninterrupted sleep apnea therapy in absence of power supply
8.2.6.3 Transportation accessories
8.2.6.3.1 Need to carry sleep apnea devices while traveling to spur segment growth
8.2.6.4 Communication accessories
8.2.6.4.1 Increasing need for easy teleconsultations for remote patients to fuel segment growth
8.2.6.5 Chain restraints
8.2.6.5.1 Growing need for obstructive sleep apnea management with therapeutic devices to drive segment
8.2.6.6 Other accessories
8.2.7 ORAL APPLIANCES
8.2.7.1 Mandibular advancement devices
8.2.7.1.1 Low cost and better research on device advantages to propel market growth
8.2.7.2 Tongue-retaining devices
8.2.7.2.1 Need for more affordable and comfortable treatment options to support segment growth
8.2.7.3 Daytime-Nighttime appliances
8.2.7.3.1 Increased focus on comfortable, non-surgical, and low-risk treatments to drive segment
8.2.8 OTHER THERAPEUTIC DEVICES
8.3 DIAGNOSTIC DEVICES
8.3.1 PSG DEVICES
8.3.1.1 Ambulatory PSG devices
8.3.1.1.1 High need for cost-effective and technologically advanced devices to propel segment growth
8.3.1.2 Clinical PSG devices
8.3.1.2.1 Labor-intensive and expensive procedures to limit segment
8.3.2 HOME SLEEP TESTING DEVICES
8.3.2.1 Increased need for cost-effective and comfortable home sleep testing devices to augment segment growth
8.3.3 OXIMETERS
8.3.3.1 Fingertip oximeters
8.3.3.1.1 Lack of precise reading due to injury or slow blood flow to limit segment
8.3.3.2 Handheld oximeters
8.3.3.2.1 Easy customizations and ease of distant reading to spur segment growth
8.3.3.3 Wrist-worn oximeters
8.3.3.3.1 Small size and easy portability for overnight monitoring to propel segment growth
8.3.3.4 Tabletop oximeters
8.3.3.4.1 Higher cost and fewer applications for personal use to decrease market share
8.3.4 ACTIGRAPHY SYSTEMS
8.3.4.1 Increased research on sleep and wake patterns to drive market
8.3.5 SLEEP SCREENING DEVICES
8.3.5.1 Increasing preference for home-based sleep apnea testing to propel market growth
9 SLEEP APNEA DEVICES MARKET, BY END USER (Page No. - 143)
9.1 INTRODUCTION
9.2 SLEEP LABORATORIES, CLINICS, AND HOSPITALS
9.2.1 INCREASING NEED FOR ADVANCED DIAGNOSTIC DEVICES AND HIGHLY PRECISE DIAGNOSIS TO SUPPORT MARKET GROWTH
9.3 HOME CARE SETTINGS/INDIVIDUALS
9.3.1 INCREASING PATIENT PREFERENCE FOR HOME-BASED SLEEP TESTS TO FUEL MARKET GROWTH
10 SLEEP APNEA DEVICES MARKET, BY AGE GROUP (Page No. - 148)
10.1 INTRODUCTION
10.2 BELOW 40 YEARS
10.2.1 LOWER PREVALENCE OF SLEEP APNEA IN YOUNGER AGE GROUPS TO LIMIT MARKET GROWTH
10.3 40–60 YEARS
10.3.1 UNDERDIAGNOSIS AND UNHEALTHY LIFESTYLE TO AID MARKET GROWTH
10.4 ABOVE 60 YEARS
10.4.1 HIGH OCCURRENCE OF CHRONIC MEDICAL CONDITIONS AND SLEEP-RELATED DISORDERS TO DRIVE MARKET
11 SLEEP APNEA DEVICES MARKET, BY GENDER (Page No. - 153)
11.1 INTRODUCTION
11.2 MALE PATIENTS
11.2.1 HIGHER PREVALENCE OF SLEEP-RELATED BREATHING DISORDERS TO BOOST MARKET GROWTH
11.3 FEMALE PATIENTS
11.3.1 UNDERDIAGNOSIS OF OBSTRUCTIVE SLEEP APNEA TO LIMIT MARKET
12 SLEEP APNEA DEVICES MARKET, BY REGION (Page No. - 157)
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 US
12.2.1.1 US to dominate North American sleep apnea devices market during forecast period
12.2.2 CANADA
12.2.2.1 Increasing number of research grants and health programs to propel market growth
12.3 EUROPE
12.3.1 GERMANY
12.3.1.1 High prevalence of obstructive sleep apnea and increased geriatric population to fuel market
12.3.2 UK
12.3.2.1 Rising awareness among patients about sleep apnea to support market growth
12.3.3 FRANCE
12.3.3.1 Rising geriatric population and obesity rates to fuel market growth
12.3.4 ITALY
12.3.4.1 Favorable initiatives by dental associations and increased awareness about obstructive sleep apnea to drive market
12.3.5 SPAIN
12.3.5.1 Social awareness initiatives by regional organizations to aid market growth
12.3.6 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 CHINA
12.4.1.1 Growing obesity and diabetes in adults to propel market growth
12.4.2 JAPAN
12.4.2.1 Favorable reimbursement scenario and high demand for cloud-connected sleep apnea therapeutic devices to aid market growth
12.4.3 AUSTRALIA
12.4.3.1 Increased number of sleep clinics to augment market growth
12.4.4 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 BRAZIL
12.5.1.1 Favorable reimbursement policies and increased awareness about sleeping disorders to drive market
12.5.2 MEXICO
12.5.2.1 Poor healthcare infrastructure and lack of public health initiatives to limit market growth
12.5.3 REST OF LATIN AMERICA
12.6 MIDDLE EAST & AFRICA
12.6.1 PRESENCE OF KEY INTERNATIONAL PLAYERS AND HIGH INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET
12.7 GCC COUNTRIES
12.7.1 SAUDI ARABIA
12.7.1.1 High obesity rates among women to propel market growth
12.7.2 UAE
12.7.2.1 Improved access to diagnostics to drive adoption of sleep apnea devices
12.8 REST OF GCC COUNTRIES
13 COMPETITIVE LANDSCAPE (Page No. - 298)
13.1 INTRODUCTION
13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SLEEP APNEA DEVICES MARKET
13.3 REVENUE ANALYSIS
13.4 MARKET SHARE ANALYSIS
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
13.5.5.1 Company footprint
13.5.5.2 Product footprint
13.5.5.3 Region footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
13.7 COMPANY VALUATION & FINANCIAL METRICS
13.8 BRAND/PRODUCT COMPARISON
13.9 COMPETITIVE SCENARIO
13.9.1 PRODUCT LAUNCHES & APPROVALS
13.9.2 DEALS
13.9.3 EXPANSIONS
13.9.4 OTHER DEVELOPMENTS
14 COMPANY PROFILES (Page No. - 313)
14.1 KEY PLAYERS
14.1.1 RESMED
14.1.1.1 Business overview
14.1.1.2 Products offered
14.1.1.3 Recent developments
14.1.1.3.1 Product launches
14.1.1.3.2 Deals
14.1.1.3.3 Expansions
14.1.1.4 MnM view
14.1.1.4.1 Key strengths
14.1.1.4.2 Strategic choices
14.1.1.4.3 Weaknesses & competitive threats
14.1.2 KONINKLIJKE PHILIPS N.V.
14.1.2.1 Business overview
14.1.2.2 Products offered
14.1.2.3 MnM view
14.1.2.3.1 Key strengths
14.1.2.3.2 Strategic choices
14.1.2.3.3 Weaknesses & competitive threats
14.1.3 FISHER & PAYKEL HEALTHCARE LIMITED
14.1.3.1 Business overview
14.1.3.2 Products offered
14.1.3.3 Recent developments
14.1.3.3.1 Product launches
14.1.3.4 MnM view
14.1.3.4.1 Key strengths
14.1.3.4.2 Strategic choices
14.1.3.4.3 Weaknesses & competitive threats
14.1.4 INSPIRE MEDICAL SYSTEMS, INC.
14.1.4.1 Business overview
14.1.4.2 Products offered
14.1.5 SOMNOMED
14.1.5.1 Business overview
14.1.5.2 Products offered
14.1.6 OPENAIRWAY
14.1.6.1 Business overview
14.1.6.2 Products offered
14.1.7 COMPUMEDICS LIMITED
14.1.7.1 Business overview
14.1.7.2 Products offered
14.1.7.3 Recent developments
14.1.7.3.1 Product approvals
14.1.8 LOWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG
14.1.8.1 Business overview
14.1.8.2 Products offered
14.1.9 DRIVE DEVILBISS HEALTHCARE
14.1.9.1 Business overview
14.1.9.2 Products offered
14.1.10 BMC MEDICAL CO., LTD.
14.1.10.1 Business overview
14.1.10.2 Products offered
14.1.11 BRAEBON MEDICAL CORPORATION
14.1.11.1 Business overview
14.1.11.2 Products offered
14.1.12 DYNAFLEX
14.1.12.1 Business overview
14.1.12.2 Products offered
14.1.12.3 Recent developments
14.1.12.3.1 Deals
14.1.13 PANTHERA DENTAL
14.1.13.1 Business overview
14.1.13.2 Products offered
14.1.13.3 Recent developments
14.1.13.3.1 Deals
14.1.13.3.2 Other developments
14.1.14 MYERSON LLC
14.1.14.1 Business overview
14.1.14.2 Products offered
14.1.15 PROSOMNUS SLEEP TECHNOLOGIES
14.1.15.1 Business overview
14.1.15.2 Products offered
14.1.15.3 Recent developments
14.1.15.3.1 Deals
14.2 OTHER PLAYERS
14.2.1 NIDEK MEDICAL INDIA
14.2.2 TOMED GMBH
14.2.3 LIVANOVA PLC
14.2.3.1 Recent developments
14.2.3.1.1 Product approvals
14.2.4 INVACARE CORPORATION
14.2.5 MPOWRX HEALTH & WELLNESS PRODUCTS INC.
14.2.6 NIHON KOHDEN CORPORATION
14.2.7 SICAT GMBH & CO. KG
14.2.8 VIVOS THERAPEUTICS, INC.
14.2.8.1 Recent developments
14.2.8.1.1 Product approvals
14.2.8.1.2 Deals
14.2.8.1.3 Expansions
14.2.9 AIRWAY MANAGEMENT
14.2.9.1 Recent developments
14.2.9.1.1 Product launches
14.2.10 APNEA SCIENCES
15 APPENDIX (Page No. - 358)
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS
LIST OF TABLES (483 TABLE)
TABLE 1 SLEEP APNEA DEVICES MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 SLEEP APNEA DEVICES MARKET: KEY DATA FROM PRIMARY SOURCES
TABLE 3 SLEEP APNEA DEVICES MARKET: RISK ASSESSMENT
TABLE 4 ESTIMATED PREVALENCE OF SLEEP APNEA, 2022–2024 (MILLION)
TABLE 5 REIMBURSEMENT CODES AND COSTS OF KEY SLEEP APNEA DEVICES BY RESMED
TABLE 6 ESTABLISHED CPT CODES PROVIDED BY ITAMAR MEDICAL LTD.
TABLE 7 INITIATIVES TO PROMOTE AWARENESS ABOUT EFFECTS OF UNTREATED SLEEP APNEA
TABLE 8 LIST OF ADVANCED ORAL APPLIANCES AVAILABLE FOR TREATING SLEEP APNEA
TABLE 9 AVERAGE SELLING PRICE OF SLEEP APNEA PRODUCTS, BY REGION
TABLE 10 AVERAGE SELLING PRICE RANGE, BY PRODUCT TYPE, 2021–2023
TABLE 11 SLEEP APNEA DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SLEEP APNEA DEVICES (%)
TABLE 13 KEY BUYING CRITERIA FOR END USERS OF SLEEP APNEA DEVICES
TABLE 14 SLEEP APNEA DEVICES MARKET: ROLE IN ECOSYSTEM
TABLE 15 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 16 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 17 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
TABLE 18 CHINA: CLASSIFICATION OF MEDICAL DEVICES
TABLE 19 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24 LIST OF OTHER REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25 SLEEP APNEA DEVICES MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2024−DECEMBER 2025
TABLE 26 IMPORT DATA FOR HS CODE 901920, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 27 EXPORT DATA FOR HS CODE 901920, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 28 SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 29 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 30 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 31 PAP DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 32 PAP DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 33 CPAP DEVICES OFFERED BY KEY PLAYERS
TABLE 34 CPAP DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 35 APAP DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 36 BPAP DEVICES OFFERED BY KEY PLAYERS
TABLE 37 BPAP DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 38 FACIAL INTERFACES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 39 FACIAL INTERFACES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 40 MASKS OFFERED BY KEY PLAYERS
TABLE 41 MASKS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 42 MASKS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 43 FULL-FACE MASKS OFFERED BY KEY PLAYERS
TABLE 44 FULL-FACE MASKS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 45 NASAL PILLOW MASKS OFFERED BY KEY PLAYERS
TABLE 46 NASAL PILLOW MASKS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 47 NASAL MASKS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 48 CUSHIONS OFFERED BY KEY PLAYERS
TABLE 49 CUSHIONS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 50 ACCESSORIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 51 ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 52 HUMIDIFIER ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 53 POWER ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 54 TRANSPORTATION ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 55 COMMUNICATION ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 56 CHIN RESTRAINTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 57 OTHER ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 58 ORAL APPLIANCES OFFERED BY KEY PLAYERS
TABLE 59 ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 60 ORAL APPLIANCES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 61 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 62 TONGUE-RETAINING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 63 DAYTIME-NIGHTTIME APPLIANCES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 64 OTHER THERAPEUTIC DEVICES OFFERED BY KEY PLAYERS
TABLE 65 OTHER THERAPEUTIC DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 66 SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 67 SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 68 PSG DEVICES OFFERED BY KEY PLAYERS
TABLE 69 PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 70 PSG DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 71 AMBULATORY PSG DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 72 CLINICAL PSG DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 73 HOME SLEEP TESTING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 74 OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 75 OXIMETERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 76 FINGERTIP OXIMETERS OFFERED BY KEY PLAYERS
TABLE 77 FINGERTIP OXIMETERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 78 HANDHELD OXIMETERS OFFERED BY KEY PLAYERS
TABLE 79 HANDHELD OXIMETERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 80 WRIST-WORN OXIMETERS OFFERED BY KEY PLAYERS
TABLE 81 WRIST-WORN OXIMETERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 82 TABLETOP OXIMETERS OFFERED BY KEY PLAYERS
TABLE 83 TABLETOP OXIMETERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 84 LIST OF JOURNALS THAT ASSESS ROLE OF ACTIGRAPHY SYSTEMS IN SLEEP APNEA
TABLE 85 ACTIGRAPHY SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 86 SLEEP SCREENING DEVICES OFFERED BY KEY PLAYERS
TABLE 87 SLEEP SCREENING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 88 SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 89 SLEEP APNEA DEVICES MARKET FOR SLEEP LABORATORIES, CLINICS, AND HOSPITALS, BY REGION, 2022–2029 (USD MILLION)
TABLE 90 SLEEP APNEA DEVICES MARKET FOR HOME CARE SETTINGS/INDIVIDUALS, BY REGION, 2022–2029 (USD MILLION)
TABLE 91 SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
TABLE 92 SLEEP APNEA DEVICES MARKET FOR BELOW 40 YEARS, BY REGION, 2022–2029 (USD MILLION)
TABLE 93 SLEEP APNEA DEVICES MARKET FOR 40–60 YEARS, BY REGION, 2022–2029 (USD MILLION)
TABLE 94 SLEEP APNEA DEVICES MARKET FOR ABOVE 60 YEARS, BY REGION, 2022–2029 (USD MILLION)
TABLE 95 SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
TABLE 96 SLEEP APNEA DEVICES MARKET FOR MALE PATIENTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 97 SLEEP APNEA DEVICES MARKET FOR FEMALE PATIENTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 98 SLEEP APNEA DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 99 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 100 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 101 NORTH AMERICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 102 NORTH AMERICA: PAP DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 103 NORTH AMERICA: FACIAL INTERFACES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 104 NORTH AMERICA: MASKS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 105 NORTH AMERICA: ACCESSORIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 106 NORTH AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 107 NORTH AMERICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 108 NORTH AMERICA: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 109 NORTH AMERICA: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 110 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 111 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
TABLE 112 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
TABLE 113 US: SLEEP APNEA PRODUCTS OFFERED BY KEY PLAYERS
TABLE 114 US: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 115 US: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 116 US: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (THOUSAND UNITS)
TABLE 117 US: PAP DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 118 US: FACIAL INTERFACES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 119 US: MASKS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 120 US: ACCESSORIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 121 US: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 122 US: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 123 US: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 124 US: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 125 US: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 126 US: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
TABLE 127 US: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
TABLE 128 CANADA: SLEEP APNEA PRODUCTS OFFERED BY KEY PLAYERS
TABLE 129 CANADA: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 130 CANADA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 131 CANADA: PAP DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 132 CANADA: FACIAL INTERFACES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 133 CANADA: MASKS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 134 CANADA: ACCESSORIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 135 CANADA: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 136 CANADA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 137 CANADA: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 138 CANADA: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 139 CANADA: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 140 CANADA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
TABLE 141 CANADA: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
TABLE 142 EUROPE: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 143 EUROPE: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 144 EUROPE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 145 EUROPE: PAP DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 146 EUROPE: FACIAL INTERFACES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 147 EUROPE: MASKS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 148 EUROPE: ACCESSORIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 149 EUROPE: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 150 EUROPE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 151 EUROPE: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 152 EUROPE: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 153 EUROPE: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 154 EUROPE: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
TABLE 155 EUROPE: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
TABLE 156 GERMANY: SLEEP APNEA PRODUCTS PROVIDED BY MAJOR PLAYERS
TABLE 157 GERMANY: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 158 GERMANY: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 159 GERMANY: PAP DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 160 GERMANY: FACIAL INTERFACES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 161 GERMANY: MASKS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 162 GERMANY: ACCESSORIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 163 GERMANY: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 164 GERMANY: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 165 GERMANY: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 166 GERMANY: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 167 GERMANY: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 168 GERMANY: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
TABLE 169 GERMANY: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
TABLE 170 UK: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 171 UK: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 172 UK: PAP DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 173 UK: FACIAL INTERFACES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 174 UK: MASKS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 175 UK: ACCESSORIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 176 UK: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 177 UK: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 178 UK: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 179 UK: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 180 UK: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 181 UK: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
TABLE 182 UK: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
TABLE 183 FRANCE: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 184 FRANCE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 185 FRANCE: PAP DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 186 FRANCE: FACIAL INTERFACES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 187 FRANCE: MASKS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 188 FRANCE: ACCESSORIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 189 FRANCE: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 190 FRANCE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 191 FRANCE: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 192 FRANCE: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 193 FRANCE: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 194 FRANCE: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
TABLE 195 FRANCE: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
TABLE 196 ITALY: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 197 ITALY: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 198 ITALY: PAP DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 199 ITALY: FACIAL INTERFACES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 200 ITALY: MASKS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 201 ITALY: ACCESSORIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 202 ITALY: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 203 ITALY: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 204 ITALY: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 205 ITALY: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 206 ITALY: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 207 ITALY: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
TABLE 208 ITALY: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
TABLE 209 SPAIN: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 210 SPAIN: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 211 SPAIN: PAP DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 212 SPAIN: FACIAL INTERFACES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 213 SPAIN: MASKS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 214 SPAIN: ACCESSORIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 215 SPAIN: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 216 SPAIN: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 217 SPAIN: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 218 SPAIN: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 219 SPAIN: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 220 SPAIN: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
TABLE 221 SPAIN: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
TABLE 222 REST OF EUROPE: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 223 REST OF EUROPE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 224 REST OF EUROPE: PAP DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 225 REST OF EUROPE: FACIAL INTERFACES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 226 REST OF EUROPE: MASKS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 227 REST OF EUROPE: ACCESSORIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 228 REST OF EUROPE: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 229 REST OF EUROPE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 230 REST OF EUROPE: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 231 REST OF EUROPE: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 232 REST OF EUROPE: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 233 REST OF EUROPE: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
TABLE 234 REST OF EUROPE: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
TABLE 235 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 236 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 237 ASIA PACIFIC: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 238 ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 239 ASIA PACIFIC: FACIAL INTERFACES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 240 ASIA PACIFIC: MASKS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 241 ASIA PACIFIC: ACCESSORIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 242 ASIA PACIFIC: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 243 ASIA PACIFIC: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 244 ASIA PACIFIC: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 245 ASIA PACIFIC: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 246 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 247 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
TABLE 248 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
TABLE 249 CHINA: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 250 CHINA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 251 CHINA: PAP DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 252 CHINA: FACIAL INTERFACES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 253 CHINA: MASKS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 254 CHINA: ACCESSORIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 255 CHINA: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 256 CHINA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 257 CHINA: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 258 CHINA: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 259 CHINA: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 260 CHINA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
TABLE 261 CHINA: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
TABLE 262 JAPAN: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 263 JAPAN: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 264 JAPAN: PAP DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 265 JAPAN: FACIAL INTERFACES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 266 JAPAN: MASKS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 267 JAPAN: ACCESSORIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 268 JAPAN: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 269 JAPAN: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 270 JAPAN: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 271 JAPAN: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 272 JAPAN: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 273 JAPAN: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
TABLE 274 JAPAN: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
TABLE 275 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 276 AUSTRALIA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 277 AUSTRALIA: PAP DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 278 AUSTRALIA: FACIAL INTERFACES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 279 AUSTRALIA: MASKS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 280 AUSTRALIA: ACCESSORIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 281 AUSTRALIA: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 282 AUSTRALIA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 283 AUSTRALIA: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 284 AUSTRALIA: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 285 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 286 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
TABLE 287 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
TABLE 288 REST OF ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 289 REST OF ASIA PACIFIC: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 290 REST OF ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 291 REST OF ASIA PACIFIC: FACIAL INTERFACES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 292 REST OF ASIA PACIFIC: MASKS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 293 REST OF ASIA PACIFIC: ACCESSORIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 294 REST OF ASIA PACIFIC: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 295 REST OF ASIA PACIFIC: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 296 REST OF ASIA PACIFIC: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 297 REST OF ASIA PACIFIC: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 298 REST OF ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 299 REST OF ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
TABLE 300 REST OF ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
TABLE 301 LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 302 LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 303 LATIN AMERICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 304 LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 305 LATIN AMERICA: FACIAL INTERFACES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 306 LATIN AMERICA: MASKS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 307 LATIN AMERICA: ACCESSORIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 308 LATIN AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 309 LATIN AMERICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 310 LATIN AMERICA: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 311 LATIN AMERICA: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 312 LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 313 LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
TABLE 314 LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
TABLE 315 BRAZIL: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 316 BRAZIL: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 317 BRAZIL: PAP DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 318 BRAZIL: FACIAL INTERFACES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 319 BRAZIL: MASKS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 320 BRAZIL: ACCESSORIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 321 BRAZIL: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 322 BRAZIL: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 323 BRAZIL: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 324 BRAZIL: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 325 BRAZIL: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 326 BRAZIL: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
TABLE 327 BRAZIL: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
TABLE 328 MEXICO: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 329 MEXICO: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 330 MEXICO: PAP DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 331 MEXICO: FACIAL INTERFACES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 332 MEXICO: MASKS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 333 MEXICO: ACCESSORIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 334 MEXICO: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 335 MEXICO: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 336 MEXICO: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 337 MEXICO: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 338 MEXICO: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 339 MEXICO: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
TABLE 340 MEXICO: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
TABLE 341 REST OF LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 342 REST OF LATIN AMERICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 343 REST OF LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 344 REST OF LATIN AMERICA: FACIAL INTERFACES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 345 REST OF LATIN AMERICA: MASKS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 346 REST OF LATIN AMERICA: ACCESSORIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 347 REST OF LATIN AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 348 REST OF LATIN AMERICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 349 REST OF LATIN AMERICA: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 350 REST OF LATIN AMERICA: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 351 REST OF LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 352 REST OF LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
TABLE 353 REST OF LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
TABLE 354 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 355 MIDDLE EAST & AFRICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 356 MIDDLE EAST & AFRICA: PAP DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 357 MIDDLE EAST & AFRICA: FACIAL INTERFACES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 358 MIDDLE EAST & AFRICA: MASKS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 359 MIDDLE EAST & AFRICA: ACCESSORIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 360 MIDDLE EAST & AFRICA: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 361 MIDDLE EAST & AFRICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 362 MIDDLE EAST & AFRICA: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 363 MIDDLE EAST & AFRICA: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 364 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 365 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
TABLE 366 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
TABLE 367 GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 368 GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 369 GCC COUNTRIES: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 370 GCC COUNTRIES: PAP DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 371 GCC COUNTRIES: FACIAL INTERFACES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 372 GCC COUNTRIES: MASKS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 373 GCC COUNTRIES: ACCESSORIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 374 GCC COUNTRIES: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 375 GCC COUNTRIES: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 376 GCC COUNTRIES: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 377 GCC COUNTRIES: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 378 GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 379 GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
TABLE 380 GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
TABLE 381 SAUDI ARABIA: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 382 SAUDI ARABIA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 383 SAUDI ARABIA: PAP DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 384 SAUDI ARABIA: FACIAL INTERFACES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 385 SAUDI ARABIA: MASKS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 386 SAUDI ARABIA: ACCESSORIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 387 SAUDI ARABIA: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 388 SAUDI ARABIA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 389 SAUDI ARABIA: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 390 SAUDI ARABIA: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 391 SAUDI ARABIA: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 392 SAUDI ARABIA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
TABLE 393 SAUDI ARABIA: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
TABLE 394 UAE: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 395 UAE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 396 UAE: PAP DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 397 UAE: FACIAL INTERFACES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 398 UAE: MASKS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 399 UAE: ACCESSORIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 400 UAE: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 401 UAE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 402 UAE: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 403 UAE: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 404 UAE: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 405 UAE: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
TABLE 406 UAE: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
TABLE 407 REST OF GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 408 REST OF GCC COUNTRIES: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 409 REST OF GCC COUNTRIES: PAP DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 410 REST OF GCC COUNTRIES: FACIAL INTERFACES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 411 REST OF GCC COUNTRIES: MASKS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 412 REST OF GCC COUNTRIES: ACCESSORIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 413 REST OF GCC COUNTRIES: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 414 REST OF GCC COUNTRIES: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 415 REST OF GCC COUNTRIES: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 416 REST OF GCC COUNTRIES: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 417 REST OF GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 418 REST OF GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
TABLE 419 REST OF GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
TABLE 420 OVERVIEW OF STRATEGIES ADOPTED BY KEY SLEEP APNEA DEVICE MANUFACTURING COMPANIES
TABLE 421 SLEEP APNEA DEVICES MARKET: DEGREE OF COMPETITION
TABLE 422 SLEEP APNEA DEVICES MARKET: PRODUCT FOOTPRINT
TABLE 423 SLEEP APNEA DEVICES MARKET: REGION FOOTPRINT
TABLE 424 SLEEP APNEA DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 425 SLEEP APNEA DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 426 SLEEP APNEA DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021– JUNE 2024
TABLE 427 SLEEP APNEA DEVICES MARKET: DEALS, JANUARY 2021– JUNE 2024
TABLE 428 SLEEP APNEA DEVICES MARKET: EXPANSIONS, JANUARY 2021– JUNE 2024
TABLE 429 SLEEP APNEA DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024
TABLE 430 RESMED: COMPANY OVERVIEW
TABLE 431 RESMED: PRODUCTS OFFERED
TABLE 432 RESMED: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
TABLE 433 RESMED: DEALS, JANUARY 2021–JUNE 2024
TABLE 434 RESMED: EXPANSIONS, JANUARY 2021–JUNE 2024
TABLE 435 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
TABLE 436 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
TABLE 437 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY OVERVIEW
TABLE 438 FISHER & PAYKEL HEALTHCARE LIMITED: PRODUCTS OFFERED
TABLE 439 FISHER & PAYKEL HEALTHCARE LIMITED: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
TABLE 440 INSPIRE MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW
TABLE 441 INSPIRE MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED
TABLE 442 SOMNOMED: COMPANY OVERVIEW
TABLE 443 SOMNOMED: PRODUCTS OFFERED
TABLE 444 OPENAIRWAY: COMPANY OVERVIEW
TABLE 445 OPENAIRWAY: PRODUCTS OFFERED
TABLE 446 COMPUMEDICS LIMITED: COMPANY OVERVIEW
TABLE 447 COMPUMEDICS LIMITED: PRODUCTS OFFERED
TABLE 448 COMPUMEDICS LIMITED: PRODUCT APPROVALS, JANUARY 2021–JUNE 2024
TABLE 449 LOWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG: COMPANY OVERVIEW
TABLE 450 LOWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG: PRODUCTS OFFERED
TABLE 451 DRIVE DEVILBISS HEALTHCARE: COMPANY OVERVIEW
TABLE 452 DRIVE DEVILBISS HEALTHCARE: PRODUCTS OFFERED
TABLE 453 BMC MEDICAL CO., LTD.: COMPANY OVERVIEW
TABLE 454 BMC MEDICAL CO., LTD.: PRODUCTS OFFERED
TABLE 455 BRAEBON MEDICAL CORPORATION: COMPANY OVERVIEW
TABLE 456 BRAEBON MEDICAL CORPORATION: PRODUCTS OFFERED
TABLE 457 DYNAFLEX: COMPANY OVERVIEW
TABLE 458 DYNAFLEX.: PRODUCTS OFFERED
TABLE 459 DYNAFLEX: DEALS, JANUARY 2021–JUNE 2024
TABLE 460 PANTHERA DENTAL: COMPANY OVERVIEW
TABLE 461 PANTHERA DENTAL: PRODUCTS OFFERED
TABLE 462 PANTHERA DENTAL: DEALS, JANUARY 2021–JUNE 2024
TABLE 463 PANTHERA DENTAL: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024
TABLE 464 MYERSON LLC: COMPANY OVERVIEW
TABLE 465 MYERSON LLC: PRODUCTS OFFERED
TABLE 466 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY OVERVIEW
TABLE 467 PROSOMNUS SLEEP TECHNOLOGIES: PRODUCTS OFFERED
TABLE 468 PROSOMNUS SLEEP TECHNOLOGIES: DEALS, JANUARY 2021–JUNE 2024
TABLE 469 NIDEK MEDICAL INDIA: COMPANY OVERVIEW
TABLE 470 TOMED GMBH: COMPANY OVERVIEW
TABLE 471 LIVANOVA PLC: COMPANY OVERVIEW
TABLE 472 LIVANOVA PLC: PRODUCT APPROVALS, JANUARY 2021–JUNE 2024
TABLE 473 INVACARE CORPORATION: COMPANY OVERVIEW
TABLE 474 MPOWRX HEALTH & WELLNESS PRODUCTS INC.: COMPANY OVERVIEW
TABLE 475 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
TABLE 476 SICAT GMBH & CO. KG: COMPANY OVERVIEW
TABLE 477 VIVOS THERAPEUTICS, INC.: COMPANY OVERVIEW
TABLE 478 VIVOS THERAPEUTICS, INC.: PRODUCT APPROVALS, JANUARY 2021–JUNE 2024
TABLE 479 VIVOS THERAPEUTICS, INC.: DEALS, JANUARY 2021–JUNE 2024
TABLE 480 VIVOS THERAPEUTICS, INC.: EXPANSIONS, JANUARY 2021–JUNE 2024
TABLE 481 AIRWAY MANAGEMENT: COMPANY OVERVIEW
TABLE 482 AIRWAY MANAGEMENT: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
TABLE 483 APNEA SCIENCES: COMPANY OVERVIEW
LIST OF FIGURES (50 FIGURES)
FIGURE 1 SLEEP APNEA DEVICES MARKET: SEGMENTS COVERED
FIGURE 2 SLEEP APNEA DEVICES MARKET: REGIONS COVERED
FIGURE 3 SLEEP APNEA DEVICES MARKET: YEARS CONSIDERED
FIGURE 4 SLEEP APNEA DEVICES MARKET: RESEARCH DESIGN
FIGURE 5 LIST OF KEY PRIMARIES (DEMAND AND SUPPLY SIDES)
FIGURE 6 SLEEP APNEA DEVICES MARKET: KEY INDUSTRY INSIGHTS
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 8 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
FIGURE 9 BOTTOM-UP APPROACH: PATIENT-BASED ANALYSIS
FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 11 SLEEP APNEA DEVICES MARKET: TOP-DOWN APPROACH
FIGURE 12 DATA TRIANGULATION METHODOLOGY
FIGURE 13 SLEEP APNEA DEVICES MARKET: STUDY ASSUMPTIONS
FIGURE 14 SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
FIGURE 15 SLEEP APNEA DEVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 16 SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2024 VS. 2029 (USD MILLION)
FIGURE 17 SLEEP APNEA DEVICES MARKET, BY GENDER, 2024 VS. 2029 (USD MILLION)
FIGURE 18 SLEEP APNEA DEVICES MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
FIGURE 19 LARGE POOL OF UNDIAGNOSED SLEEP APNEA PATIENTS TO DRIVE MARKET
FIGURE 20 THERAPEUTIC DEVICES SEGMENT TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
FIGURE 21 US AND THERAPEUTIC DEVICES SEGMENT ACCOUNTED FOR LARGER MARKET SHARES IN 2023
FIGURE 22 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
FIGURE 23 SLEEP APNEA DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 24 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
FIGURE 25 SUPPLY CHAIN ANALYSIS: DIRECT DISTRIBUTION TO BE PREFERRED STRATEGY OF PROMINENT COMPANIES
FIGURE 26 SLEEP APNEA DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SLEEP APNEA DEVICES
FIGURE 28 KEY BUYING CRITERIA FOR END USERS OF SLEEP APNEA DEVICES
FIGURE 29 SLEEP APNEA DEVICES MARKET: ECOSYSTEM MAP
FIGURE 30 TOP 10 COMPANIES WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014–2023
FIGURE 31 REVENUE SHIFT IN SLEEP APNEA DEVICES MARKET
FIGURE 32 INVESTMENT & FUNDING SCENARIO FOR KEY PLAYERS (2018−2023)
FIGURE 33 SLEEP APNEA DEVICES MARKET: PRESCRIPTION PATTERN ASSESSMENT
FIGURE 34 NORTH AMERICA: SLEEP APNEA DEVICES MARKET SNAPSHOT
FIGURE 35 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET SNAPSHOT
FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN SLEEP APNEA DEVICES MARKET, 2021−2023 (USD MILLION)
FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS IN SLEEP APNEA DEVICES MARKET (2023)
FIGURE 38 SLEEP APNEA DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 39 SLEEP APNEA DEVICES MARKET: COMPANY FOOTPRINT
FIGURE 40 SLEEP APNEA DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 41 EV/EBITDA OF KEY VENDORS
FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 43 SLEEP APNEA DEVICES MARKET: PRODUCT COMPARATIVE ANALYSIS FOR CPAP DEVICES
FIGURE 44 RESMED: COMPANY SNAPSHOT (2023)
FIGURE 45 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023)
FIGURE 46 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY SNAPSHOT (2024)
FIGURE 47 INSPIRE MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2023)
FIGURE 48 SOMNOMED: COMPANY SNAPSHOT (2023)
FIGURE 49 COMPUMEDICS LIMITED: COMPANY SNAPSHOT (2023)
FIGURE 50 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY SNAPSHOT (2023)
The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, restraints, challenges, and key player strategies. To track company developments such as acquisitions, product launches and approvals, expansions, agreements, and partnerships of the leading players, the competitive landscape of the sleep apnea devices market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.
The four steps involved in estimating the market size are
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.
The following is a breakdown of the primary respondents:
Breakdown of Primary Participants:
Note 1: Others include sales managers, marketing managers, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2022/2023, Tier 1 = >USD 1 million, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
|
COMPANY NAME |
DESIGNATION |
|
SOMNOmedcis AG (Germany) |
Country Manager |
|
ResMed (US) |
Regional Sales Manager |
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the sleep apnea devices market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research
- The revenues generated by leading players operating in the sleep apnea devices market have been determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Sleep apnea devices Market Size: Bottom Up Approach
To know about the assumptions considered for the study, Request for Free Sample Report
Global Sleep apnea devices Market Size: Top-Down Approach
Data Triangulation
After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Sleep apnea is a common sleep disorder that usually goes undiagnosed but has serious and life-threatening effects. The disease involves abnormal pauses in breathing, ranging from a few seconds to minutes, or the occurrence of an abnormal breathing rate; the most common type is obstructive sleep apnea. Sleep apnea devices help force air into the nasal passages at high pressure to overcome obstructions in the airway and stimulate normal breathing.
Key Stakeholders
- Senior Management
- Sleep Laboratories, Clinics, & Hospitals
- Home Care Settings
- Academic & research institutes
- Finance/Procurement Department
- R&D Department
Report Objectives
- To define, describe, segment, and forecast the global sleep apnea devices market by product, end user, age group, gender and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, challenges, and trends)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall sleep apnea devices market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to six regions—North America, Europe, the Asia Pacific, Latin America, Middle East & Africa, and GCC Countries
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
Available Customizations
MarketsandMarkets offers the following customizations for this market report.
Country Information
- Additional country-level analysis of the sleep apnea devices market
Company profiles
- Additional five company profiles of players operating in the sleep apnea devices market.
Product Analysis
- Product matrix, which provides a detailed comparison of the product portfolio of each company in the sleep apnea devices market
Generating Response ...
Growth opportunities and latent adjacency in Sleep Apnea Devices Market
Which of the end user segment is supposed to hold the major share of the global Sleep Apnea Devices Market?
Which factors are responsible for boosting the global growth of Sleep Apnea Devices Market?